Literature DB >> 28424455

Flow virometry analysis of envelope glycoprotein conformations on individual HIV virions.

Anush Arakelyan1, Wendy Fitzgerald1, Deborah F King2, Paul Rogers2, Hannah M Cheeseman2, Jean-Charles Grivel1,3, Robin J Shattock4, Leonid Margolis5.   

Abstract

HIV-1 envelope proteins (Envs) play a critical role in HIV infection. In a correct trimeric conformation, Env mediates virus-cell binding and fusion. Malfunctioning of this machinery renders virions incapable of infecting cells. Each HIV-1 virion carries 10-14 Envs, and therefore a defective Env may not necessarily render a HIV virion non-infectious, since other Env on the same virion may still be functional. Alternatively, it is possible that on a given virion either all the spikes are defective or all are functional. Here, we investigate Env conformations on individual virions using our new nanotechnology, "flow virometry", and a panel of antibodies that discriminate between various Env conformations. We found that the majority of HIV-1 virions carry either only trimeric ("functional") or only defective spikes. The relatively small subfraction of virions that carry both functional and nonfunctional Envs contributes little to HIV infection of human lymphoid tissue ex vivo. The observation that the majority of virions exclusively express either functional or nonfunctional forms of Env has important implications for understanding the role of neutralizing and non-neutralizing antibodies in the immune control of HIV infection as well as for the development of effective prophylactic strategies.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28424455      PMCID: PMC5430429          DOI: 10.1038/s41598-017-00935-w

Source DB:  PubMed          Journal:  Sci Rep        ISSN: 2045-2322            Impact factor:   4.379


  38 in total

1.  Vaccinology: precisely tuned antibodies nab HIV.

Authors:  Paul R Clapham; Shan Lu
Journal:  Nature       Date:  2011-09-21       Impact factor: 49.962

2.  Nanoparticle-based flow virometry for the analysis of individual virions.

Authors:  Anush Arakelyan; Wendy Fitzgerald; Leonid Margolis; Jean-Charles Grivel
Journal:  J Clin Invest       Date:  2013-08-08       Impact factor: 14.808

3.  Structural delineation of a quaternary, cleavage-dependent epitope at the gp41-gp120 interface on intact HIV-1 Env trimers.

Authors:  Claudia Blattner; Jeong Hyun Lee; Kwinten Sliepen; Ronald Derking; Emilia Falkowska; Alba Torrents de la Peña; Albert Cupo; Jean-Philippe Julien; Marit van Gils; Peter S Lee; Wenjie Peng; James C Paulson; Pascal Poignard; Dennis R Burton; John P Moore; Rogier W Sanders; Ian A Wilson; Andrew B Ward
Journal:  Immunity       Date:  2014-04-24       Impact factor: 31.745

4.  HIV-1 neutralizing antibodies display dual recognition of the primary and coreceptor binding sites and preferential binding to fully cleaved envelope glycoproteins.

Authors:  Yuxing Li; Sijy O'Dell; Richard Wilson; Xueling Wu; Stephen D Schmidt; Carl-Magnus Hogerkorp; Mark K Louder; Nancy S Longo; Christian Poulsen; Javier Guenaga; Bimal K Chakrabarti; Nicole Doria-Rose; Mario Roederer; Mark Connors; John R Mascola; Richard T Wyatt
Journal:  J Virol       Date:  2012-08-08       Impact factor: 5.103

5.  Elimination of retroviral infectivity by N-ethylmaleimide with preservation of functional envelope glycoproteins.

Authors:  David R Morcock; James A Thomas; Tracy D Gagliardi; Robert J Gorelick; J David Roser; Elena N Chertova; Julian W Bess; David E Ott; Quentin J Sattentau; Ines Frank; Melissa Pope; Jeffrey D Lifson; Louis E Henderson; Bruce J Crise
Journal:  J Virol       Date:  2005-02       Impact factor: 5.103

6.  Rational design of envelope identifies broadly neutralizing human monoclonal antibodies to HIV-1.

Authors:  Xueling Wu; Zhi-Yong Yang; Yuxing Li; Carl-Magnus Hogerkorp; William R Schief; Michael S Seaman; Tongqing Zhou; Stephen D Schmidt; Lan Wu; Ling Xu; Nancy S Longo; Krisha McKee; Sijy O'Dell; Mark K Louder; Diane L Wycuff; Yu Feng; Martha Nason; Nicole Doria-Rose; Mark Connors; Peter D Kwong; Mario Roederer; Richard T Wyatt; Gary J Nabel; John R Mascola
Journal:  Science       Date:  2010-07-08       Impact factor: 47.728

7.  Stoichiometry of envelope glycoprotein trimers in the entry of human immunodeficiency virus type 1.

Authors:  Xinzhen Yang; Svetla Kurteva; Xinping Ren; Sandra Lee; Joseph Sodroski
Journal:  J Virol       Date:  2005-10       Impact factor: 5.103

8.  Antigenic composition of single nano-sized extracellular blood vesicles.

Authors:  Anush Arakelyan; Oxana Ivanova; Elena Vasilieva; Jean-Charles Grivel; Leonid Margolis
Journal:  Nanomedicine       Date:  2014-12-03       Impact factor: 5.307

9.  The broadly neutralizing anti-human immunodeficiency virus type 1 antibody 2G12 recognizes a cluster of alpha1-->2 mannose residues on the outer face of gp120.

Authors:  Christopher N Scanlan; Ralph Pantophlet; Mark R Wormald; Erica Ollmann Saphire; Robyn Stanfield; Ian A Wilson; Hermann Katinger; Raymond A Dwek; Pauline M Rudd; Dennis R Burton
Journal:  J Virol       Date:  2002-07       Impact factor: 5.103

10.  Discrete partitioning of HIV-1 Env forms revealed by viral capture.

Authors:  Daniel J Stieh; Deborah F King; Katja Klein; Yoann Aldon; Paul F McKay; Robin J Shattock
Journal:  Retrovirology       Date:  2015-09-24       Impact factor: 4.602

View more
  15 in total

Review 1.  Flow Virometry: a Powerful Tool To Functionally Characterize Viruses.

Authors:  Roger Lippé
Journal:  J Virol       Date:  2018-01-17       Impact factor: 5.103

2.  Flow Cytometry Analysis of HIV-1 Env Conformations at the Surface of Infected Cells and Virions: Role of Nef, CD4, and SERINC5.

Authors:  Isabelle Staropoli; Jérémy Dufloo; Olivier Schwartz; Nicoletta Casartelli; Anaïs Ducher; Pierre-Henri Commere; Anna Sartori-Rupp; Sophie Novault; Timothée Bruel; Valérie Lorin; Hugo Mouquet
Journal:  J Virol       Date:  2020-02-28       Impact factor: 5.103

Review 3.  Flow virometry as a tool to study viruses.

Authors:  J Lizbeth Reyes Zamora; Hector C Aguilar
Journal:  Methods       Date:  2017-12-16       Impact factor: 3.608

Review 4.  Modern Techniques for the Isolation of Extracellular Vesicles and Viruses.

Authors:  Ryan P McNamara; Dirk P Dittmer
Journal:  J Neuroimmune Pharmacol       Date:  2019-09-12       Impact factor: 4.147

Review 5.  Tools for Visualizing HIV in Cure Research.

Authors:  Julia Niessl; Amy E Baxter; Daniel E Kaufmann
Journal:  Curr HIV/AIDS Rep       Date:  2018-02       Impact factor: 5.071

6.  Mechanisms of residual immune activation in HIV-1-infected human lymphoid tissue ex vivo.

Authors:  Vincenzo Mercurio; Wendy Fitzgerald; Christophe Vanpouille; Ivan Molodtsov; Leonid Margolis
Journal:  AIDS       Date:  2021-07-01       Impact factor: 4.632

7.  A heterogeneous human immunodeficiency virus-like particle (VLP) formulation produced by a novel vector system.

Authors:  Joshua Pankrac; Katja Klein; Paul F McKay; Deborah F L King; Katie Bain; Jason Knapp; Tsigereda Biru; Chanuka N Wijewardhana; Rahul Pawa; David H Canaday; Yong Gao; Sarah Fidler; Robin J Shattock; Eric J Arts; Jamie F S Mann
Journal:  NPJ Vaccines       Date:  2018-01-19       Impact factor: 7.344

8.  Single-Particle Discrimination of Retroviruses from Extracellular Vesicles by Nanoscale Flow Cytometry.

Authors:  Vera A Tang; Tyler M Renner; Anna K Fritzsche; Dylan Burger; Marc-André Langlois
Journal:  Sci Rep       Date:  2017-12-19       Impact factor: 4.379

9.  Concurrent Exposure of Neutralizing and Non-neutralizing Epitopes on a Single HIV-1 Envelope Structure.

Authors:  Krishanu Ray; Meron Mengistu; Chiara Orlandi; Marzena Pazgier; George K Lewis; Anthony L DeVico
Journal:  Front Immunol       Date:  2019-07-05       Impact factor: 7.561

10.  Peptide Triazole Thiol Irreversibly Inactivates Metastable HIV-1 Env by Accessing Conformational Triggers Intrinsic to Virus-Cell Entry.

Authors:  Charles Gotuaco Ang; Erik Carter; Ann Haftl; Shiyu Zhang; Adel A Rashad; Michele Kutzler; Cameron F Abrams; Irwin M Chaiken
Journal:  Microorganisms       Date:  2021-06-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.